Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 58,818 | 69,802 | 69,462 | 101,685 | 53,333 |
| Cost of Goods | 4,606 | 5,955 | 4,753 | 4,504 | 4,409 |
| Gross Profit | 54,212 | 63,847 | 64,709 | 97,181 | 48,924 |
| Operating Expenses | 42,933 | 41,632 | 37,042 | 36,582 | 36,560 |
| Operating Income | 11,885 | 23,170 | 28,420 | 61,103 | 12,773 |
| Interest Expense | 1,433 | 1,699 | 1,894 | 1,874 | 1,853 |
| Other Income | 1,205 | 1,243 | 1,094 | 753 | 591 |
| Pre-tax Income | 11,657 | 22,714 | 27,620 | 59,982 | 11,511 |
| Income Tax | 3,003 | -245,351 | -280 | 369 | 65 |
| Net Income Continuous | 8,654 | 268,065 | 27,900 | 59,613 | 11,446 |
| Net Income | $8,654 | $268,065 | $27,900 | $59,613 | $11,446 |
| EPS Basic Total Ops | 0.47 | 14.88 | 1.55 | 3.33 | 0.64 |
| EPS Basic Continuous Ops | 0.47 | 14.88 | 1.55 | 3.33 | 0.64 |
| EPS Diluted Total Ops | 0.44 | 14.11 | 1.46 | 3.28 | 0.63 |
| EPS Diluted Continuous Ops | 0.44 | 14.11 | 1.46 | 3.28 | 0.63 |
| EPS Diluted Before Non-Recurring Items | 0.44 | 1.14 | 1.46 | 3.28 | 0.63 |
| EBITDA(a) | $12,312 | $23,528 | $28,556 | $61,460 | $13,187 |